Billable / Specific Code
ICD-10-CM C32.1 is the diagnosis code for Malignant neoplasm of supraglottis. This code falls under the section "Malignant neoplasms of respiratory and intrathoracic organs" within Chapter 2 â Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions are not included in C32.1. If the patient has both, code each condition separately:
Understanding where C32.1 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, C32.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C32.1 is the ICD-10-CM diagnosis code for "Malignant neoplasm of supraglottis". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C32.1 is C32 ("Malignant neoplasm of larynx"). C32.1 provides a more specific classification within this category.
C32.1 is located in Section C30-C39 â "Malignant neoplasms of respiratory and intrathoracic organs" within Chapter 2 of the ICD-10-CM Tabular List.
Use C32.1 when the patients documented diagnosis matches "Malignant neoplasm of supraglottis" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of supraglottis is C32.1.
Yes, C32.1 can be used as a primary diagnosis code since it is billable and specific.
C32.1 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C32.1 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.